WORLD HEALTH ORGANIZATION

Two Phase 2b clinical trials led by LMU University Hospital Munich demonstrated that sutezolid and delpazolid, both oxazolidinone antibiotics, offer safer alternatives to linezolid for tuberculosis treatment with no cases of nerve damage or blood toxicity observed.

The Indian Council of Medical Research (ICMR) and Panacea Biotec have initiated India's first Phase 3 clinical trial for an indigenous tetravalent dengue vaccine called DengiAll.

Bharat Biotech and GSK announced they will reduce the price of the world's first malaria vaccine RTS,S by more than half to less than $5 per dose by 2028.

Trinity Biotech received World Health Organization approval for offshored and outsourced upstream manufacturing of its TrinScreen HIV rapid test, marking a critical milestone in the company's transformation plan.

The antiviral drug Favipiravir demonstrated substantial protection against Chandipura virus in preclinical studies conducted by India's National Institute of Virology.

CanSino Biologics has launched iPneucia®, a 13-valent pneumococcal conjugate vaccine specifically optimized for China's local pneumococcal epidemiology to protect Chinese children.

A large retrospective cohort study of 19,720 patients found that dupilumab treatment for atopic dermatitis was associated with a 58% increased risk of developing psoriasis compared to other systemic therapies.

A peer-reviewed study published in Nature Scientific Reports demonstrates statistically significant abdominal fat reduction using Alma's Accent Prime ultrasound and radiofrequency technology in Korean women with abdominal obesity.

GeoVax Labs received positive Scientific Advice from the European Medicines Agency for GEO-MVA, a Modified Vaccinia Ankara-based vaccine targeting Mpox and smallpox prevention.

A randomized controlled trial involving 292 children across four African countries found that intravenous rehydration was as safe as oral rehydration for children with severe acute malnutrition and gastroenteritis.